
High prevalence of serine protease inhibitor Kazal type 1 gene variations detected by whole gene sequencing in patients with fibrocalculous pancreatic diabetes
Author(s) -
Anish Kolly,
C Shivaprasad,
Annie A Pulikkal,
Sridevi Atluri,
Vijaya Sarathi,
C S Dwarakanath
Publication year - 2017
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/ijem.ijem_116_17
Subject(s) - sanger sequencing , medicine , type 2 diabetes , genotype , pancreatitis , gastroenterology , gene , population , genetics , diabetes mellitus , biology , dna sequencing , endocrinology , environmental health
The aim is to study the prevalence and pattern of serine protease inhibitor Kazal type 1 (SPINK1) gene variations in patients with fibrocalculous pancreatic diabetes (FCPD) using whole gene sequencing.